Abstract
Clenbuterol, a β2-adrenergic agonist, is often misused by athletes for its anabolic and lipolytic properties. When combined with supplements like L-carnitine, the risk of cardiovascular side effects may be amplified. We present the case of a 28-year-old female amateur bodybuilder who developed new-onset atrial fibrillation after the concurrent use of clenbuterol and L-carnitine. The patient had no prior history of structural heart disease. Electrocardiography showed rapid irregular rhythm consistent with atrial fibrillation. Sinus rhythm was restored with medical cardioversion. This case highlights the arrhythmogenic potential of β-agonist abuse in young athletes and emphasizes the importance of cardiovascular monitoring in supplement users.
Keywords: Clenbuterol, L-carnitine, atrial fibrillation, athlete, arrhythmia
References
Moriarty N, Attar N. Clenbuterol-induced myocarditis: a case report. Eur J Case Rep Intern Med. 2020;7(9):001662.
Lopes PM, Albuquerque F, Ferreira AM, Trabulo M. Clenbuterol-induced myocarditis in a young man desiring to lose weight. BMJ Case Rep. 2022;15(3):e247898.
Daubert GP, Mabasa VH, Leung VW, Aaron C. Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation. J Med Toxicol. 2007;3(2):56-60.
Shafrir A, Leibowitz DW, Alcalai R, Elitzur Y, Muszkat M. Myocardial injury induced by the long-acting beta2-adrenergic agonist clenbuterol. Cardiol Cardiovasc Med. 2019;3(4):186-192
